We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$16.8B
AUM Growth
+$3.24B
Cap. Flow
+$4.87B
Cap. Flow %
28.99%
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$169M
2
KO icon
Coca-Cola
KO
+$155M
3
MCD icon
McDonald's
MCD
+$140M
4
MDLZ icon
Mondelez International
MDLZ
+$127M
5
DRE
Duke Realty Corp.
DRE
+$120M

Sector Composition

Rank Sector Weight
1 Technology 20.63%
2 Financials 11.8%
3 Healthcare 10.7%
4 Industrials 9.22%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHL
1901
DELISTED
Greenhill & Co., Inc.
GHL
$129K ﹤0.01%
21,716
-42,485
-66% -$335K
CIA icon
1902
Citizens
CIA
$256M
$128K ﹤0.01%
38,240
-3,495
-8% -$13.3K
HYEM icon
1903
VanEck Emerging Markets High Yield Bond ETF
HYEM
$521M
$128K ﹤0.01%
+7,568
New +$133K
TIPX icon
1904
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.02B
$128K ﹤0.01%
+7,040
New +$136K
WMPN
1905
DELISTED
William Penn Bancorporation Common Stock
WMPN
$128K ﹤0.01%
+11,282
New +$130K
ZY
1906
DELISTED
Zymergen Inc. Common Stock
ZY
$127K ﹤0.01%
45,532
-25,572
-36% -$62.1K
PTH icon
1907
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$221M
$126K ﹤0.01%
+3,120
New +$132K
VKTX icon
1908
Viking Therapeutics
VKTX
$3.93B
$126K ﹤0.01%
46,186
+19,863
+75% +$65.1K
LTRX icon
1909
Lantronix
LTRX
$232M
$125K ﹤0.01%
26,000
+6,546
+34% +$39.8K
CTXR icon
1910
Citius Pharmaceuticals
CTXR
$15.8M
$124K ﹤0.01%
4,107
-744
-15% -$20.4K
FREL icon
1911
Fidelity MSCI Real Estate Index ETF
FREL
$1.53B
$124K ﹤0.01%
5,186
+3,349
+182% +$93.3K
VTWO icon
1912
Vanguard Russell 2000 ETF
VTWO
$17.4B
$123K ﹤0.01%
1,848
+1,648
+824% +$121K
SMHI icon
1913
SEACOR Marine Holdings
SMHI
$212M
$122K ﹤0.01%
21,758
+3,395
+18% +$21.3K
OEF icon
1914
iShares S&P 100 ETF
OEF
$19.9B
$120K ﹤0.01%
741
-467
-39% -$84.8K
SRRK icon
1915
Scholar Rock
SRRK
$5.94B
$120K ﹤0.01%
17,349
-2,222
-11% -$18.5K
EIDO icon
1916
iShares MSCI Indonesia ETF
EIDO
$469M
$119K ﹤0.01%
5,109
-245,501
-98% -$5.73M
ESRT icon
1917
Empire State Realty Trust
ESRT
$1.01B
$119K ﹤0.01%
18,110
-11,804
-39% -$87.6K
FRGE
1918
DELISTED
Forge Global Holdings
FRGE
$119K ﹤0.01%
+4,527
New +$311K
KG
1919
Kestrel Group
KG
$66.7M
$119K ﹤0.01%
2,771
-676
-20% -$28.7K
IVAC
1920
DELISTED
Intevac Inc
IVAC
$119K ﹤0.01%
25,566
+4,394
+21% +$21.3K
GDXJ icon
1921
VanEck Junior Gold Miners ETF
GDXJ
$7.1B
$118K ﹤0.01%
4,001
-218,231
-98% -$6.77M
KBA icon
1922
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$148M
$118K ﹤0.01%
+3,905
New +$134K
TBF icon
1923
ProShares Short 20+ Year Treasury ETF
TBF
$86.3M
$118K ﹤0.01%
5,293
+5,127
+3,089% +$104K
LCTX icon
1924
Lineage Cell Therapeutics
LCTX
$264M
$117K ﹤0.01%
103,322
+13,362
+15% +$19.6K
MLPA icon
1925
Global X MLP ETF
MLPA
$2.28B
$117K ﹤0.01%
2,978
-10,696
-78% -$433K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review

As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
  • Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
  • Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
  • Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.